Systematic Multi-Domain Alzheimer’s Risk Reduction Trial (SMARRT): Study Protocol
Kristine Yaffe(University of California, San Francisco), Eric B. Larson(University of Washington), Kristin J. Adams(Kaiser Permanente Washington Health Research Institute), Deborah E. Barnes(University of California, San Francisco), Anne Renz(Kaiser Permanente Washington Health Research Institute), Dori E. Rosenberg(Kaiser Permanente Washington Health Research Institute), Allison R. Kaup(University of California, San Francisco), Carrie Peltz(San Francisco VA Health Care System), Evette Ludman(Kaiser Permanente Washington Health Research Institute), Eric Vittinghoff(University of California, San Francisco), Sascha Dublin(Kaiser Permanente Washington Health Research Institute)
Cited by 37
Related Papers
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the <i>CKR5</i> Structural Gene
|Science|1996|2.5k
Collaborative Care for Patients with Depression and Chronic Illnesses
|New England Journal of Medicine|2010|1.7k
Relationship of Depression and Diabetes Self-Care, Medication Adherence, and Preventive Care
|Diabetes Care|2004|1.2k
Functional Status of Elderly Adults before and after Initiation of Dialysis
|New England Journal of Medicine|2009|1k